Proactive Formed for Cancer Biomarker Platform
A new European consortium has been formed to develop a platform for detecting protein-based disease biomarkers.
Called Proactive, the consortium comprises six industry and academic institution partners and is coordinated by Olink Bioscience, based in Uppsala, Sweden.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.